(Reuters) -The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be ...
The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.
2d
Zacks Investment Research on MSNSanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track TagSanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of ...
2d
GlobalData on MSNFDA fast tracks Sanofi’s mRNA vaccine for chlamydiaSanofi will soon commence a Phase I/II trial with its vaccine candidate to start generating immunogenicity data.
Chlamydia vaccine candidate granted fast track designation by the US FDAChlamydia infection can contribute to pelvic inflammatory diseases in ...
For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...
10d
Green Matters on MSNUncovering the Crisis: Why Do So Many Koalas Have Chlamydia?Koalas are facing a shocking health crisis: widespread chlamydia infections — so are they born with the STD and how do they ...
The US Food and Drug Administration (FDA) today approved the first at-home, over-the-counter test for chlamydia, gonorrhea, and trichomoniasis.
The Food and Drug Administration (FDA) has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.
1don MSN
While there’s been a slight dip in STD rates across the country, the South continues to see infection levels that raise ...
Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...
Chlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to pregnancy complications or infertility A phase 1/2 clinical study evaluating the immunogenicity and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results